Skip to main content

Table 4 All Conporto EDM Alerts

From: Medication risk management and health equity in New Zealand general practice: a retrospective cross-sectional study

Alert

N

(% of all events)

Notified

(% of event)

Actioned

(% of notified)

Macrolide & Simvastatin

425 (26.4)

363 (85.4)

239 (65.8)

NSAID eGFR < 45

372 (23.1)

302 (81.2)

165 (54.6)

Meformin eGFR < 30

187 (11.6)

161 (86.1)

113 (70.2)

Valproate F

178 (11.1)

157 (88.2)

63 (40.1)

Valproate F epilepsy

163 (10.1)

160 (98.2)

48 (30.0)

MTX no folic acid

155 (9.6)

118 (76.1)

98 (83.1)

PDEi & Nitrite

51 (3.2)

44 (86.3)

29 (65.9)

Allopurinol > 200 mg eGFR < 30

43 (2.7)

24 (55.8)

21 (87.5)

NSAID, ulcer, no PPI

33 (2.1)

25 (75.8)

15 (60.0)

Buproprion epilepsy

4 (0.3)

4 (100)

0 (0)

Total

1611 (100)

1358 (84.3)

791 (58.2)